CPD bite: Stłuszczenie wątroby i cukrzyca typu 2
W tym materiale FIP CPD Bite skupiającym się na stłuszczeniowej chorobie wątroby i cukrzycy typu 2, omówiono strategie zarządzania dla pacjentów żyjących z tymi schorzeniami. Omówiono również warunki kliniczne, które podkreślają zawiłości zarządzania stłuszczeniem wątroby wraz z cukrzycą typu 2, a także najnowsze podejścia do wsparcia pacjentów i zarządzania chorobami. Celem tego szkolenia jest przekazanie farmaceutom wiedzy i umiejętności pozwalających na zapewnienie skutecznej opieki pacjentom zmagającym się ze złożonością stłuszczenia wątroby i cukrzycy typu 2.
CPD bite: Fatty liver disease and type 2 diabetes
In this FIP CPD Bite focusing on fatty liver disease and type 2 diabetes, management strategies for patients living with these conditions are explored. Clinical settings that highlight the intricacies of managing fatty liver disease alongside type 2 diabetes are also covered, as well as the latest approaches in patient support and disease management. This CPD Bite aims to offer pharmacists knowledge and skills to provide effective care for patients grappling with the complexities of fatty liver disease and type 2 diabetes.
Diabetes prevention, screening and management: A handbook for pharmacists (2021)
This handbook supports the Practice Transformation Programme on Diabetes. It presents an overview of diabetes and describes the various services pharmacists can provide aiming at disease prevention, screening, disease state management and treatment optimisation.
Knowledge and skills reference guide for professional development in diabetes (2022)
Πρόληψη, έλεγχος και διαχείριση του διαβήτη, Eγχειρίδιο για φαρμακοποιούς
Ο διαβήτης είναι μια χρόνια ασθένεια που εμφανίζεται όταν το πάγκρεας δεν παράγει αρκετή
ινσουλίνη ή όταν το σώμα δεν μπορεί να χρησιμοποιήσει σωστά την ινσουλίνη που παράγει.
Prevenção, rastreio e gestão da diabetes: Um manual para farmacêuticos.
A diabetes é um importante problema de saúde pública que afeta aproximadamente um em cada 10 adultos globalmente, sendo a diabetes tipo 2 responsável por 90-95% dos casos. Embora os farmacêuticos sejam formados principalmente para resolver problemas de saúde com medicamentos adequados e seguros, também possuem as competências e os conhecimentos necessários para prestar serviços de prevenção e rastreio. Os farmacêuticos estão numa posição privilegiada para prestar uma vasta gama de serviços de prevenção, identificação e gestão da diabetes tipo 1 e tipo 2, bem como apoiar os cuidados prestados por outros membros da equipa dos cuidados de saúde.
糖尿病预防、筛查和管理:药师手册 (2021)
本手册支持糖尿病的实践转型计划。它介绍了糖尿病的概况,并描述了药师可以提供的各种服务,旨在预防疾病、筛查、疾病状态管理和优化治疗。
FIP 专业知识和技能参考指南:糖尿病药师手册的配套资料 (2022)
新的糖尿病参考指南着重于帮助药剂师达到所需的能力:
“糖尿病专业发展的知识和技能参考指南”。
自2006年以来,FIP一直在倡导药剂师在预防和治疗包括糖尿病在内的慢性疾病方面的作用,这份最新的指南旨在作为2021年出版的FIP药剂师糖尿病手册的补充,将帮助药剂师确定和获得他们为糖尿病患者提供服务所需的能力,如筛查和临床管理。
除了支持药师在其职业发展过程中提升自己的技能外,FIP的新出版物还旨在指导继续职业发展机构设计和提供教育和培训课程。该指南承认,在一些国家,提供糖尿病相关服务存在一些障碍和规定,但强调 “临床医生和卫生政策制定者应始终大力考虑将药剂师纳入多学科的糖尿病护理团队”。
Prevención, detección y gestión de la diabetes: Un manual para farmacéuticos (2021)
Este manual apoya el Programa de Transformación de la Práctica Profesional en Diabetes. Presenta una visión general de la diabetes y describe los distintos servicios que pueden prestar los farmacéuticos con vistas a la prevención de la enfermedad, el cribado, la gestión del estado de la enfermedad y la optimización del tratamiento.
Diyabetin önlenmesi, taranması ve yönetimi: Eczacılar için bir kılavuz. (2021)
Bu el kitabı Diyabet Uygulama Dönüşüm Programını desteklemektedir. Diyabete genel bir bakış sunmakta ve eczacıların hastalık önleme, tarama, hastalık durumu yönetimi ve tedavi optimizasyonuna yönelik sağlayabilecekleri çeşitli hizmetleri açıklamaktadır.
Nutrition and weight management services: a toolkit for pharmacists (2021)
This toolkit provides an international collection of best practices of professional services, evidence and guidance for nutrition-related and weight-management services both for pharmacist organisations and individual practitioners.
Beating non-communicable diseases in the community: The contribution of pharmacists (2019)
This reference paper provides global evidence to advocate, nationally and internationally, for an expanded role for pharmacists in NCD management by compiling best practices and examples. It also encourages pharmacists around the world to act upon NCDs.
FIP statement of policy on “The role of pharmacists in non-communicable diseases” (2019)
This FIP statement of policy renews the commitment of the profession to the optimal prevention, detection and care of patients living with NCDs. It replaces the 2006 FIP Policy Statement on the role of the pharmacist in the prevention and treatment of chronic diseases.
Pharmacists’ contribution to diabetes care (2011)
This briefing document presents different activities for diabetes prevention and care that pharmacists are involved in.